Journal of the American Chemical Society · 2008 · 476 citations · 24 references
PharmacyBiotechnologyPharmaceuticsBiocompatibilityDrug DeliveryVaccinologyDrug EncapsulationNanocarriers For TherapeuticsNanoparticle CharacterizationNanoparticle FormulationsVaccine DeliveryVaccine Delivery SystemsBiodegradable MicroparticlesCytotoxicity AssaysDrug-delivery ApplicationsMicroparticlesNanoparticle CytotoxicityNanoparticle Vaccine FormulationsPh DependenceVaccine Delivery Formulations
Dextran, a biocompatible, water-soluble polysaccharide, was modified at its hydroxyls with acetal moieties such that it became insoluble in water but freely soluble in common organic solvents enabling its use in the facile preparation of acid-sensitive microparticles. These particles degrade in a pH-dependent manner: FITC-dextran was released with a half-life at 37 degrees C of 10 h at pH 5.0 compared to a half-life of approximately 15 days at pH 7.4. Both hydrophobic and hydrophilic cargoes were successfully loaded into these particles using single and double emulsion techniques, respectively. When used in a model vaccine application, particles loaded with the protein ovalbumin (OVA) increased the presentation of OVA-derived peptides to CD8+ T-cells 16-fold relative to OVA alone. Additionally, this dextran derivative was found to be nontoxic in preliminary in vitro cytotoxicity assays. Owing to its ease of preparation, processability, pH-sensitivity, and biocompatibility, this type of modified dextran should find use in numerous drug delivery applications.
24
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Shiladitya Sengupta, David A. Eavarone, Ishan Capila et al. · Nature · 2005 · 943 citations
Pharmacy, Oncology, Pharmaceutics +16
General Pharmacology The Vascular System · 1997 · 749 citations
Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism.
Gabriel Helmlinger, Axel Sckell, Marc Dellian et al. · PubMed · 2002 · 424 citations